|
|
|
|
LEADER |
01011naa a2200313 i 4500 |
001 |
NSK01001039566 |
003 |
HR-ZaNSK |
005 |
20190909122223.0 |
007 |
ta |
008 |
190902s2017 ci | |0|| ||hrv |
035 |
|
|
|a (HR-ZaNSK)001039566
|
040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
041 |
0 |
|
|a hrv
|b eng
|
042 |
|
|
|a croatica
|
044 |
|
|
|a ci
|c hr
|
080 |
1 |
|
|a 615
|2 2011
|
100 |
1 |
|
|a Matković, Iva
|4 aut
|
245 |
1 |
0 |
|a Klinički profil rivaroksabana /
|c Iva Matković, Ivana Samardžić, Ljubica Frančić Pranjković, Slaven Falamić, Vesna Bačić Vrca.
|
300 |
|
|
|b Ilustr.
|
504 |
|
|
|a Bibliografija: 47 jed.
|
504 |
|
|
|a Abstract
|
653 |
|
0 |
|a Oralni antikoagulans
|a Rivaroksaban
|
700 |
1 |
|
|a Samardžić, Ivana
|4 aut
|
700 |
1 |
|
|a Frančić Pranjković, Ljubica
|4 aut
|
700 |
1 |
|
|a Falamić, Slaven
|4 aut
|
700 |
1 |
|
|a Bačić Vrca, Vesna
|4 aut
|
773 |
0 |
|
|t Farmaceutski glasnik
|x 0014-8202
|g 73 (2017), 5 ; str. 343-356
|w nsk.(HR-ZaNSK)000000435
|
981 |
|
|
|b B05/17
|
998 |
|
|
|b gtao1909
|b dali1909
|